Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial
BMC cancer, pp. 2782020.
ChemoradiotherapyECOG 2EfficacyLocally advancedNon-small-cell lung cancerMore(1+)
ClinicalTrials.gov registration number: NCT01494558. (Registered 19 December 2011).
Full Text (Upload PDF)
PPT (Upload PPT)